skip to content

The Victor Phillip Dahdaleh Heart & Lung Research Institute

 
Read more at: Cambridge joins global consortium to transform antibiotic discovery against AMR

Cambridge joins global consortium to transform antibiotic discovery against AMR

23 January 2026

Researchers at the University of Cambridge are part of a major international effort exploring novel approaches to antibiotic discovery to deal with the growing threat of antimicrobial resistance (AMR).


Read more at: UK-Australia study awarded £7.4 million to investigate how menopause shapes heart health

UK-Australia study awarded £7.4 million to investigate how menopause shapes heart health

20 January 2026

A new international study co-led by the University of Cambridge has received US $10 million (approximately £7.4 million) to explore how menopause affects women’s heart health. The funding will support the largest clinical trial of its kind aimed at detecting early, silent changes in the arteries and testing whether earlier...


Read more at: Targeting the immune system could prevent future heart attacks, clinical trial suggests

Targeting the immune system could prevent future heart attacks, clinical trial suggests

9 January 2026

Joseph Cheriyan, Ziad Mallat and colleagues have discovered that an existing therapy which boosts protective immune cells in people who recently had heart attacks reduces blood vessel inflammation and may reduce the likelihood of future heart attacks.


Read more at: Hai Nguyen wins British Thoracic Society Medical Student Award

Hai Nguyen wins British Thoracic Society Medical Student Award

17 December 2025


Read more at: New study sheds light on cardiovascular disease prediction and prevention

New study sheds light on cardiovascular disease prediction and prevention

16 December 2025


Read more at: Bacteria tune their membranes to manage energy and resist drugs

Bacteria tune their membranes to manage energy and resist drugs

1 December 2025

New research led by the Universities of Cambridge and Basel shows how bacteria regulate membrane channels to control nutrient flow and antibiotic uptake, revealing a hidden mechanism of drug resistance. A new study in Nature Microbiology , co-led by Professor Andres Floto at the Victor Phillip Dahdaleh Heart & Lung...


Read more at: Professor James Rudd receives funding for cutting-edge AI health research

Professor James Rudd receives funding for cutting-edge AI health research

27 November 2025

Professor James Rudd has received new research funding from the Accelerate Programme for Scientific Discovery and the Cambridge Centre for Data-Driven Discovery for a groundbreaking project developing a coronary artery CT foundation model to improve early detection of high-risk heart disease.


Read more at: Risk of rare heart complications in children higher after COVID-19 infection than after vaccination

Risk of rare heart complications in children higher after COVID-19 infection than after vaccination

6 November 2025

Children and young people faced long-lasting and higher risks of rare heart and inflammatory complications after COVID-19 infection, compared to before or without an infection, according to new research. Meanwhile COVID-19 vaccination was only linked to a short-term higher risk of myocarditis and pericarditis.


Read more at: VPD-HLRI Monthly Seminar Series - 17th November - Prof Annemarie Docherty, Edinburgh & Dr Frank McCaughan, Cambridge

VPD-HLRI Monthly Seminar Series - 17th November - Prof Annemarie Docherty, Edinburgh & Dr Frank McCaughan, Cambridge

14 October 2025


Read more at: Professor Martin Bennett awarded UKRI proof-of-concept funding for AI-based cardiovascular project

Professor Martin Bennett awarded UKRI proof-of-concept funding for AI-based cardiovascular project

9 October 2025

A total of 48 projects from across the UK are receiving funding from a new £9 million proof of concept programme to support and accelerate the development of new or improved technologies, products, processes and services. The aim of the UKRI fund is to use research to drive growth and create the jobs of tomorrow.